The US Food and Drug Administration will be taking several factors into consideration as it decides whether to pull an emergency use authorization for COVID-19 therapeutics or require vaccines to be updated due to emerging variants of the SARS-CoV-2 virus.
Draft guidance on these topics should be available in several weeks, Acting Commissioner Janet Woodcock said on 4 February, and...